The US Apheresis Service Market is expected to grow at a substantial CAGR of 8.47% between 2025 and 2035. Apheresis is a medical technique that involves drawing blood from a patient or donor, separating a specific component (such as plasma, platelets, or white blood cells), and returning the remaining blood to the body. It is commonly employed for therapeutic objectives, including as removing excess components in particular disorders (for example, excess white blood cells in leukemia) or collecting specific blood products for transfusions, such as platelets or plasma.
The rising frequency of chronic diseases, increased demand for plasma-derived medicines, and favorable reimbursement regulations are all driving the growth of the US Apheresis Market. Furthermore, high treatment costs, safety concerns about blood transfusions, and the recruitment of voluntary non-remunerated donors are limiting issues for the industry. However, rising demand for platelet-rich plasma therapy and apheresis among leukemia and pediatric patients will present the market with future growth prospects.
Market Segmentation
The US Apheresis Service Market is divided into three service types: donor/automated apheresis, therapeutic apheresis, and stem cell collection/processing.
The US Apheresis Service Market is divided into the following applications: neurological disorders, autoimmune disorders, hematologic disorders, oncology, metabolic toxicology disorders, infectious diseases, cardiovascular disorders, and others. The Hematologic Disorders category dominated the market in 2024, while Oncology is the fastest expanding segment during the forecast period.
End users in the US Apheresis Service Market include hospitals, blood banks, specialty clinics, research laboratories, and biotechnology pharmaceutical companies.
The US Apheresis Service Market is divided into four regions: north, south, the midwest, and west. South accounted for the greatest market share in 2024, and is expected to reach USD 757.67 million by 2035, growing at the fastest CAGR of 9.63% throughout the forecast period.
Major Players
Versiti, Fresenius Medical Care, Carter BloodCare, ImpactLife, Mayo Clinic, The New York Blood Center (NYBC), The American Red, BioBridge Global, and San Diego Blood Bank (SDBB) are the leading companies in the US Apheresis Service Market.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook